The dose escalation schedule most commonly follows a four-week progression: 0.25mg for weeks one through four, then 0.5mg for weeks five through eight, continuing upward until reaching your therapeutic maintenance dose
Your body adapts and then they go away, Azagury said
[00:22:00] Okay, so if there's anything to take away from this episode is that GLP ones may be one tool, one tool in the broader treatment scope of endometriosis because of their potential on inflammation
If every patient who applies gets approved, regardless of medical history, BMI, or contraindications, the clinical oversight is performative
In December 2025, Eli Lilly submitted the drug to the FDA for weight loss and plans to submit it for type 2 diabetes in 2026
This makes the blend a particularly relevant research tool for groups seeking to generate original data on peptide combination protocols